Skip to main content
Premium Trial:

Request an Annual Quote

Thermo to Launch Commercial Version of ProSight PTM Proteomics Software in June

ORLANDO, Fla., March 2 (GenomeWeb News) - Thermo Electron will launch in June a commercial version of ProSight PTM, a software developed by the University of Illinois for identifying and characterizing intact proteins and their post-translational modifications, GenomeWeb News has learned.


The software, called ProSight PC, will be released at the ASMS meeting, to be held in San Antonio, Tex., on June 5-9, according to Amy Zumwalt, a product marketing specialist for proteomics at Thermo Electron. Thermo will be the exclusive distributor of the software, according to Zumwalt.


A non-commercial version of the software is currently available for free here, according to Neil Kelleher, the software's lead developer. Kelleher, an assistant professor of chemistry at the Universityof Illinoisat Urbana-Champaign, gave a presentation on ProSight PTM Monday at the PITTCON conference, held here this week.


ProSight PC will differ from ProSight PTM in the way it performs batch processing, said Kelleher. In addition, ProSight PC will include a new searching method referred to as the biomarker search mode. In this mode, the software specifically searches for protein fragments found in blood and tries to match them with top-down mass-spectrometry data.


"The commercial grade will be a lot more robust in terms of speed and features," Kelleher said.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.